Karyopharm Therapeutics Inc.KPTINASDAQ
Loading
Income Tax Expense Over TimeContracting
Percentile Rank50
3Y CAGR-51.2%
5Y CAGR-32.6%
Studio
Year-over-Year Change

Income taxes paid or accrued

3Y CAGR
-51.2%/yr
vs +94.1%/yr prior
5Y CAGR
-32.6%/yr
Recent deceleration
Acceleration
-145.3pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$43000.00-24.6%
2024$57000.00-82.4%
2023$323000.00-12.5%
2022$369000.00+37.7%
2021$268000.00-13.3%
2020$309000.00+672.5%
2019$40000.00+53.8%
2018$26000.00-58.7%
2017$63000.00-54.7%
2016$139000.00-